In September 2026, global markets are navigating a landscape marked by mixed performances in major indices, with the Federal Reserve's recent rate hike and fluctuating oil prices due to Middle East tensions capturing investor attention. Amidst these developments, identifying undervalued stocks becomes crucial as they offer potential opportunities for investors seeking value in a volatile environment.
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Shizuki Electric (TSE:6994) | ¥1208.00 | ¥2298.03 | 47.4% |
| RaySearch Laboratories (OM:RAY B) | SEK174.00 | SEK343.03 | 49.3% |
| Rakus (TSE:3923) | ¥1082.00 | ¥2063.55 | 47.6% |
| PAL GROUP Holdings (TSE:2726) | ¥1486.00 | ¥2881.64 | 48.4% |
| Niterra (TSE:5334) | ¥7218.00 | ¥13807.95 | 47.7% |
| KSB SE KGaA (XTRA:KSB) | €880.00 | €1758.24 | 49.9% |
| Koninklijke BAM Groep (ENXTAM:BAMNB) | €11.99 | €23.07 | 48% |
| Cheil Worldwide (KOSE:A030000) | ₩17580.00 | ₩33785.57 | 48% |
| Apator (WSE:APT) | PLN25.00 | PLN48.82 | 48.8% |
| AK Medical Holdings (SEHK:1789) | HK$4.915 | HK$9.57 | 48.7% |
Let's uncover some gems from our specialized screener.
Overview: Promotora y Operadora de Infraestructura S. A. B. de C. V (BMV:PINFRA) operates in the infrastructure sector, focusing on the development, operation, and maintenance of highways and other transport-related projects, with a market cap of MX$109.30 billion.
Operations: The company's revenue is derived from three main segments: Plants at MX$576.20 million, Concessions at MX$15.24 billion, and Construction at MX$6.22 billion.
Estimated Discount To Fair Value: 44.8%
Promotora y Operadora de Infraestructura S.A.B. de C.V. recently reported sales of MX$6.08 billion for Q2 2026, up from MX$4.93 billion a year ago, although net income decreased to MX$1.77 billion from MX$2.14 billion. Despite this decline, the stock is trading at a significant discount to its estimated fair value and future cash flow value, suggesting it may be undervalued based on cash flows despite forecasted earnings declines over the next three years.
Overview: RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer treatment globally, with a market cap of SEK5.85 billion.
Operations: RaySearch Laboratories generates revenue primarily from its healthcare software segment, amounting to SEK1.27 billion.
Estimated Discount To Fair Value: 49.3%
RaySearch Laboratories is trading at SEK174, significantly below its estimated cash flow value of SEK343.03, indicating potential undervaluation based on cash flows. Despite recent earnings declines, with Q2 2026 sales at SEK272.3 million compared to last year's SEK304.9 million, the company forecasts robust annual profit growth of 25.9%. Recent collaborations and product enhancements in radiation therapy software further strengthen its market position and future revenue prospects amidst a challenging financial landscape.
Overview: Beijing Kingsoft Office Software, Inc. offers office software products and services both in China and internationally, with a market cap of CN¥103.75 billion.
Operations: The company's revenue is primarily derived from its Software & Programming segment, which generated CN¥6.58 billion.
Estimated Discount To Fair Value: 31.3%
Beijing Kingsoft Office Software, trading at CN¥231.3, is significantly undervalued compared to its estimated future cash flow value of CN¥336.72. Its recent earnings report shows substantial growth with net income reaching CN¥2.52 billion for H1 2026, up from CN¥747.2 million a year ago, reflecting strong operational performance despite slower forecasted revenue and profit growth relative to the market. Additionally, a share repurchase program worth CN¥500 million highlights confidence in long-term value creation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com